BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

Clinical trial NCT06704152 · RECRUITING

Trial details

NCT number: NCT06704152
Sponsor: BlueSphere Bio, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

AML, Adult Recurrent ALL, Recurrent, Adult MDS

Start date: 2025-02-04
Primary completion: 2029-02-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.